ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing December 11, 2020, 4:00 pm ET: 

On the Road to Precision: Understanding the Biology Driving Genomic Assays (Editorial)
Kevin Kalinsky, et al.
Request this article

Rapid Conversion of a Palliative Care Outpatient Clinic to Telehealth (Original Contribution)
Vishal Gupta, et al.
Request this article

Publishing December 10, 2020, 4:00 pm ET: 

First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors (Original Report)
Richard Baird, et al.
Request this article

Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines (Original Report)
Laura Rosenberger, et al.
Request this article

Publishing December 9, 2020, 4:00 pm ET: 

Melflufen and Dexamethasone in Heavily Pre-treated Relapsed/Refractory Multiple Myeloma (Original Report)
Paul Richardson, et al.
Request this article

Publishing December 8, 2020, 4:00 pm ET: 

The American Society of Clinical Oncology Road to Recovery Report: Learning from the COVID-19 Experience to Improve Clinical Research and Cancer Care (ASCO Special Article)
Jonathan Phillips, et al.
Request this article

Publishing December 7, 2020, 4:00 pm ET: 

Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non–Small-Cell Lung Cancer (Original Contribution)
Bernardo Goulart, et al.
Request this article

Publishing December 4, 2020, 4:00 pm ET: 

Parsing the Paradox of Myelodysplastic Syndromes (Editorial)
Mikkael Sekeres, et al.
Request this article

Prostate Radiotherapy with Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-analysis (Original Report)
Daniel Spratt, et al.
Request this article

Time to change direction in the treatment of relapsed Hodgkin lymphoma? (Editorial)
Michael Crump, et al.
Request this article

Publishing December 3, 2020, 4:00 pm ET: 

Policy and Health: Leveraging a Social Determinants of Health Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer (Editorial)
Hala Borno, et al.
Request this article

State of Physician and Pharmacist Oncology Workforce in the United States in 2019 (Original Contribution)
Ya-Chen Tina Shih, et al.
Request this article

Publishing November 30, 2020, 4:00 pm ET: 

Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors (Original Report)
Debra Patt, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.